论文部分内容阅读
美国一家公司初步研制出一款可植入皮肤、藉以渗透药力的微型芯片,倘若成功日后可取代打针食药。由于芯片可定时定量地释出药物,故对长期病患者尤有益处,预计五年左右就可研究完成。定时按量释出药物 “微型芯片”(MicroCHIPS)公司创办人圣蒂尼经三年研究,研制出一款仅指甲大小、内藏数百微型药格的芯片。它由钛金属包裹,并接驳着电池,植入病人腹腔下,计算机软件便能导引芯片自动按时
A company in the United States initially developed a microchip that can be implanted into the skin to penetrate the drug if it succeeds in the future. As the chip can release drugs regularly and quantitatively, it is especially beneficial to patients with chronic diseases. It is estimated that the study will be completed in about five years. The drug is released on a regular basis. "Santini, founder of MicroCHIPS, has developed a nails-sized chip that contains hundreds of tiny druggoods after three years of research. It is wrapped by titanium and connected to the battery, implanted in the patient’s abdominal cavity, the computer software can guide the chip automatically on time